logo
Select company
Select metric
-341.12%EBIT Margin
VS
Market
8
Sector
28
Industry
51
History
88
$ 6.48Close
$ 3 - $ 24.6 52-Week Range
Ticker Information

Ticker

GBIO

Company Name

GENERATION BIO CO

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GENERATION BIO CO - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GBIO - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -72.42M-341.12%$ 21.23M
3/31/2025$ -71.93M-292.92%$ 24.56M
12/31/2024$ -131.67M-661.91%$ 19.89M
9/30/2024$ -145.47M-782.87%$ 18.58M
6/30/2024$ -158.43M-1202.56%$ 13.17M
3/31/2024$ -169.06M-1696.87%$ 9.96M
12/31/2023$ -126.61M-2144.51%$ 5.9M
9/30/2023$ -123.83M-4092.23%$ 3.03M
6/30/2023$ -126.87M-14417.16%$ 880K
3/31/2023$ -133.73M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GENERATION BIO CO's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, GENERATION BIO CO's average EBIT % has been -2848.02%.
  • The median EBIT % for GENERATION BIO CO during this period was -1202.56%
  • GENERATION BIO CO reached its highest EBIT % over the past 5 years at -292.92%.
  • The lowest EBIT % recorded by GENERATION BIO CO in the same timeframe -14417.16%

GENERATION BIO CO's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
XLO : XILIO THERAPEUTICS INC -374.79%BCAB : BIOATLA INC -541.05%CRIS : CURIS INC -341.25%PRPO : PRECIPIO INC -7.98%MRSN : MERSANA THERAPEUTICS INC -202.14%DYAI : DYADIC INTERNATIONAL INC -123.19%XFOR : X4 PHARMACEUTICALS INC -282.18%NEPH : NEPHROS INC 8.1%POCI : PRECISION OPTICS CORPORATION INC -29.08%NRXS : NEURAXIS INC -220.34%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for GENERATION BIO CO is calculated as follows: EBIT [ $ -80.52M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

GBIO - EBIT Margin, Last 5 years

-14417.16%

Minimum

Jun 30, 2023

-292.92%

Maximum

Mar 31, 2025

-2848.02%

Average

-1202.56%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.56% with a standard deviation of 23.95%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.56%
median9.02%
std23.95%